Recent Publications
Peer Reviewed Articles in Journals
Askenazi D, Goldstein SL, Chang I, Elenberg E, Feig DI. Management of a severe carbemazepine overdose using albumin-enhanced continuous veno-venous hemodialysis. Pediatrics 113(2):406-9, 2004.
Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 42(3): 247-52, 2003.
Goldstein, SL. Overview of pediatric renal replacement therapy in acute renal failure. Artif Organs. 27(9): 781-5, 2003.
Goldstein SL. Adequacy of dialysis in children: does small solute clearance really matter? Pediatr Nephrol 19(1):1-5, 2004.
Goldstein SL, Currier H, Watters L, Sheth RD, Hempe JM, Silverstein D. Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Peds 143(5): 653-7, 2003.
Goldstein SL, Smith CM, Currier H. Noninvasive interventions to decrease hospitalization and associated costs for pediatric patients receiving hemodialysis. J Am Soc Nephrol. 14(8):2127-31, 2003.
Goldstein, SL, Somers MJG, Baum MA, Mahan JD, Brophy PD, Flores FX, Blowey DL, Bunchman TE, Chua A, Alexander SR, Fortenberry J, Symons JM. The Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry: design, development and data assessed. Int J Artif Organs 27(1):9-14, 2004.
Michael M, Brewer ED, Goldstein SL. Blood volume monitoring to achieve target weight in pediatric hemodialysis patients. Pediatr Nephrol 19(4):432-7, 2004.
Michael M, Kuenhle I, Goldstein SL. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol 19(1): 91-5, 2004.
Neu AM, Fivush BA, Warady BA, Watkins SL, Friedman AL, Brem AS, Goldstein S, Frankenfield DL. Longitudinal analysis of intermediate outcomes in adolescent hemodialysis patients. Pediatr Nephrol. 18(11): 1172-6, 2003.
Sheth RD, Perez MD, Goldstein SL. Cardiovascular calcifications in pediatric patients receiving maintenance dialysis. Pediatr Nephrol. 18(8): 810-3, 2003.
Warady BA, Ellis EN, Fivush BA, Lum GM, Alexander SR, Brewer ED, Ogrinc F, Watkins SL. "Flush before fill" in children receiving automated peritoneal dialysis. Perit Dial Int. 23(5): 493-8, 2003.
Warady BA, Kausz A, Lerner G, Brewer ED, Chadha V, Brugnara C, Dahl NV, Watkins SL. Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol. (6): 655-61, 2004.
Book Chapters
Brandt ML, Brewer ED. Peritoneal dialysis access in children. In: Pediatric Dialysis, (Warady BA, Fine RN, Alexander SR and Schaefer F, eds.) Netherlands: Kluwer Academic Publishers, 2004.
Brewer ED. Evaluation of hypertension in childhood diseases. In: Pediatric Nephrology, (Avner ED, Harmon W, Niaudet P, eds.), 5th edition, Lippincott, Williams & Wilkins, Philadelphia, 2004, pp 1179-1197.
Brewer ED. The kidney. Urinary acidification. In: Fetal and Neonatal Physiology, (Polin RA, Fox WW, Abman SH, eds), 3rd edition. Philadelphia, PA: WB Saunders Company, 2004, pp 1327-1330.
Swinford RD, Elenberg E, Ingelfinger JR. Persistent renal disease. In: Nutrition in Pediatrics – Basic Science and Clinical Applications. (Walker WA, Watkins JB, Duggan C eds.), 3rd edition. Hamilton, Ontario, Canada: B.C. Decker Inc, 2003.
Abstracts
Brophy PD, Bunchman TE, Baum M, Blowey D, Fortenberry J, Somers MJG, Symons JM, Goldstein SL. Anticoagulation in pediatric hemofiltration: a report from the Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry Group. J Am Soc Neph 14:731A, 2003.*
Bunchman TE, Brophy PD, Somers MJG, Symons JM, Baum M, Fortenberry J, Blowey D, Goldstein SL. Protein and caloric delivery in pediatric CRRT: a report from the Prospective Pediatric Continuous Renal Replacement Therapy (PPCRRT) Registry Group. J Am Soc Neph 14:258A, 2003.*
Elenberg, E. Indomethacin therapy saves a child with congenital nephrotic syndrome from nephrectomy. Pediatric Research 55(4):578A, 2004.
Fadrowski J, Fivush B, Frankenfield D, Warady B, Friedman A, Goldstein SL, Neu A. Association of hemodialysis access type in pediatric hemodialysis patients and nephrologist specialization. Pediatric Research 55(4):568A, 2004 *
Fadrowski J, Fivush B, Frankenfield D, Warady B, Friedman A, Goldstein SL, Neu A. Association of mean serum albumin levels and nephrologist specialization in pediatric hemodialysis patients. Pediatric Research 55(4):568A, 2004. *
Feig DI, Johnson, RJ: Uric acid is a reversible trigger for the pediatric onset of primary hypertension. J Am Soc Neph 14:514A, 2003. *
Feig DI, Nakagawa T, Karumanchi SA, Kang D, Johnson RJ. Uric acid, nephron number and the pathogenesis of essential hypertension. Am J Hypertens 17(5):20A, 2004. **
Finch J, Mu W, Parra G, Feig DI, Kang D, Prabhakar S, Johnson RJ. Hyperuricemia induces endothelial dysfunction in rats. J Am Soc Neph 14 143A, 2003. *
Finch J, Mu W, Parra G, Feig DI, Kang D, Prabhakar S, Johnson RJ. Hyperuricemia induces endothelial dysfunction. Pediatric Research 55(4):524A, 2004. *
Fivush B, Neu A, Bedinger M, Warady B, Watkins S, Friedman A, Brem A, Goldstein SL, Frankenfield D. Impact of specialization of primary nephrologist on care of pediatric hemodialysis patients-data from CMS ESRD CPM Project. J Am Soc Neph 14:258A, 2003. *
Fivush B, Neu A, Bedinger M, Goldstein SL, Brem A, Warady B, Watkins S, Friedman A, Frankenfield D. Growth in pediatric hemodialysis patients less than 18 years data from CMS ESRD CPM Project. J Am Soc Neph 14:258A, 2003. *
Goldstein SL, Brophy PD, Somers MJG, Symons JM, Fortenberry JD, Baum MA, Bunchman TE. Continuous renal replacement therapy (CRRT) for pediatric acute renal failure: a report from the prospective pediatric CRRT (ppCRRT) registry group. Pediatric Research 55(4):566A, 2004. *
Goldstein SL, Graham N, Burwinkle, T, Warady B, Starr J, Varni JW. Health-related quality of life (HRQOL) for pediatric (Ped) ESRD patients using the PedsQL(TM) generic core scales. Pediatric Research 55(4):566A, 2004. *
Goldstein SL, Neu A, Warady B, Watkins S, Brem A, Fivush B, Friedman A, Frankenfield D. Hemodialysis variables for children less than 12 years: a report from the 2001 Center for Medicaid and Medicare (CMS) Clinical Performance Measures (CPM) Project. Pediatric Research 55(4):576A, 2004. **
Goldstein SL, Neu A, Warady B, Watkins S, Brem A, Fivush B, Friedman A, Frankenfield D. Hemodialysis variables for children less than 12 years: a report from the 2001 Center for Medicaid and Medicare (CMS) Clinical Performance Measures (CPM) Project. J Am Soc Neph 14:258A. *
Goldstein SL, Somers MJG, Symons JM, Brophy PD, Fortenberry J, Blowey D, Baum M, Bunchman TE. Pediatric multi-organ dysfunction syndrome (MODS) outcome: a report from the Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry Group. J Am Soc Neph 14:742A, 2003. *
Kommala JR, Benador N, Goldstein SL, Paredes A, Mattingly S, Amdahl M, Greenbaum L, Williams LA, Salusky I. Paricalcitol (Zemplar) injection for the treatment of secondary hyperparathyroidism in pediatric hemodialysis patients. J Am Soc Neph 14:198A, 2003. *
Neu A, Bedinger M, Fivush B, Warady B, Watkins S, Friedman A, Brem A, Goldstein SL, Frankenfield D. Growth in adolescent hemodialysis patients-longitudinal data from CMS ESRD CPM Project. J Am Soc Neph 14: 257A, 2003. *
Sheth RD, Goldstein SL. Comparison of the biointact PTH (biPTH) assay to the intact PTH (iPTH) assay in pediatric ESRD patients receiving maintenance dialysis. Pediatric Research 55(4):568A, 2004. *
Sheth RD, Goldstein SL. Comparison of the biointact PTH (biPTH) assay to the intact PTH (iPTH) assay in pediatric ESRD patients receiving maintenance dialysis. J Am Soc Neph 14: 689A, 2003. *
Somers MJG, Symons JM, Brophy PD, Blowey D, Baum MA, Bunchman TE, Fortenberry JD, Goldstein SL. Continuous renal replacement therapy in children <10 kg: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry. Pediatric Research 55(4):576A, 2004. **
Somers MJG, Baum M, Symons JM, Timothy E. Bunchman, Patrick D. Brophy, Fortenberry J, Blowey D, Goldstein SL. Continuous renal replacement therapy in children <10 kg: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group. J Am Soc Neph 14:258A, 2003. *
Symons JM, Somers MJG, Baum MA, Brophy PD, Blowey D, Fortenberry JD, Bunchman TE, Goldstein SL. Demographics of pediatric CRRT: a report of the prospective pediatric CRRT (ppCRRT) registry group. Pediatric Research 55(4):576A, 2004. **
Symons JM, Somers MJG, Baum MA, Bunchman TE, Brophy PD, Fortenberry JD, Blowey D, Goldstein SL. Demographis of pediatric CRRT: a report of the prospective pediatric CRRT (ppCRRT) registry group. J Am Soc Neph 14:830A, 2003.
Yee Dl, Kale AS, Teruya J. Thromboelastographic and PFA-100 characteristics in pediatric patients with nephrotic syndrome. Pediatric Research 55(4):287A, 2004. *
(*=poster presentation, **=oral presentation) |
